© 2019 by ATXA Therapeutics Limited.

Dublin, Ireland

Home  |  About Us  |  News  |  Contact Us

Follow us on:

  • LinkedIn Social Icon
  • Facebook Social Icon
  • Twitter Social Icon

ESC Congress Paris 2019

August 26, 2019

ATXA Therapeutics and PAH-Hope team members, Prof. Therese Kinsella & Dr. Helen Reid are looking forward to the ESC Congress 2019 next week. They will be onsite presenting preclinical findings of NTP42 for the treatment of PAH (Pulmonary Arterial Hytertension).

 

 

 

ESC Congress 2019
together with World Congress of Cardiology

Saturday 31 August - Wednesday 4 September 2019
Paris - France

 

Share on Facebook
Share on Twitter
Please reload

Please reload

Archive
Search By Tags
Recent Posts

September 30, 2019

Please reload

Please reload